Related Experiment Videos
[Autoantibodies in paraneoplastic polioencephalomyelitis: 8 cases]
J C Antoine1, J Honnorat, G Pomier
1Service de Neurologie, Hôpital de Bellevue, Saint-Etienne.
Revue Neurologique
|January 1, 1992
Summary
Researchers investigated antibodies targeting the central nervous system in patients with paraneoplastic neurological syndrome. They identified specific neuronal antibodies in patients with small-cell lung carcinoma and ovarian cancer, aiding in diagnosis.
Area of Science:
- Neuroimmunology
- Oncology
Background:
- Investigating autoimmune responses in paraneoplastic neurological syndromes (PNS) is crucial for diagnosis and treatment.
- Antibodies targeting the central nervous system (CNS) are key biomarkers in PNS.
Observation:
- Indirect immunohistochemistry was used to detect CNS-directed antibodies in patient sera.
- High antibody titers were observed in four PNS patients.
- Specific neuronal antigens were identified in patients with small-cell lung carcinoma and ovarian cancer.
Findings:
- Antibodies recognized neuronal cytoplasm and nucleus in sensory neuropathy associated with small-cell lung carcinoma, targeting a 37 Kd protein.
- An antibody against Purkinje cell cytoplasm (50-55 Kd) was found in ovarian cancer with cerebellar syndrome.
- Antibodies targeted retinal and glial cells, with immunoglobulins in white matter cells, in a patient with uveitis and cerebellar atrophy.
Implications:
- These findings highlight the diagnostic potential of specific autoantibodies in paraneoplastic neurological syndromes.
- Identification of neuronal antigens aids in understanding the pathogenesis of PNS.
- Further research into these antibodies could lead to improved diagnostic and therapeutic strategies for neurological disorders associated with cancer.